QQQ   268.72 (+0.55%)
AAPL   139.28 (+0.78%)
MSFT   235.03 (+0.91%)
META   137.35 (+1.23%)
GOOGL   97.01 (+1.42%)
AMZN   112.75 (-0.22%)
TSLA   246.33 (-7.13%)
NVDA   122.91 (+1.25%)
NIO   15.63 (-0.89%)
BABA   79.72 (-0.34%)
AMD   65.07 (+2.70%)
T   15.88 (+3.52%)
MU   52.03 (+3.85%)
CGC   2.79 (+2.20%)
F   11.35 (+1.34%)
GE   62.62 (+1.15%)
DIS   95.08 (+0.80%)
AMC   6.68 (-4.16%)
PYPL   85.68 (-0.45%)
PFE   43.66 (-0.23%)
NFLX   234.28 (-0.49%)
QQQ   268.72 (+0.55%)
AAPL   139.28 (+0.78%)
MSFT   235.03 (+0.91%)
META   137.35 (+1.23%)
GOOGL   97.01 (+1.42%)
AMZN   112.75 (-0.22%)
TSLA   246.33 (-7.13%)
NVDA   122.91 (+1.25%)
NIO   15.63 (-0.89%)
BABA   79.72 (-0.34%)
AMD   65.07 (+2.70%)
T   15.88 (+3.52%)
MU   52.03 (+3.85%)
CGC   2.79 (+2.20%)
F   11.35 (+1.34%)
GE   62.62 (+1.15%)
DIS   95.08 (+0.80%)
AMC   6.68 (-4.16%)
PYPL   85.68 (-0.45%)
PFE   43.66 (-0.23%)
NFLX   234.28 (-0.49%)
QQQ   268.72 (+0.55%)
AAPL   139.28 (+0.78%)
MSFT   235.03 (+0.91%)
META   137.35 (+1.23%)
GOOGL   97.01 (+1.42%)
AMZN   112.75 (-0.22%)
TSLA   246.33 (-7.13%)
NVDA   122.91 (+1.25%)
NIO   15.63 (-0.89%)
BABA   79.72 (-0.34%)
AMD   65.07 (+2.70%)
T   15.88 (+3.52%)
MU   52.03 (+3.85%)
CGC   2.79 (+2.20%)
F   11.35 (+1.34%)
GE   62.62 (+1.15%)
DIS   95.08 (+0.80%)
AMC   6.68 (-4.16%)
PYPL   85.68 (-0.45%)
PFE   43.66 (-0.23%)
NFLX   234.28 (-0.49%)
QQQ   268.72 (+0.55%)
AAPL   139.28 (+0.78%)
MSFT   235.03 (+0.91%)
META   137.35 (+1.23%)
GOOGL   97.01 (+1.42%)
AMZN   112.75 (-0.22%)
TSLA   246.33 (-7.13%)
NVDA   122.91 (+1.25%)
NIO   15.63 (-0.89%)
BABA   79.72 (-0.34%)
AMD   65.07 (+2.70%)
T   15.88 (+3.52%)
MU   52.03 (+3.85%)
CGC   2.79 (+2.20%)
F   11.35 (+1.34%)
GE   62.62 (+1.15%)
DIS   95.08 (+0.80%)
AMC   6.68 (-4.16%)
PYPL   85.68 (-0.45%)
PFE   43.66 (-0.23%)
NFLX   234.28 (-0.49%)
OTCMKTS:TMED

Trimedyne - TMED Stock Forecast, Price & News

$4.25
-0.01 (-0.23%)
(As of 03/20/2020)
Add
Compare
Today's Range
$4.25
$4.25
50-Day Range
$4.25
$4.25
52-Week Range
$3.48
$7.00
Volume
100 shs
Average Volume
570 shs
Market Capitalization
$522,750.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TMED stock logo

About Trimedyne (OTCMKTS:TMED) Stock

Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.

Receive TMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter.

TMED Stock News Headlines

See More Headlines
Receive TMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter.

TMED Company Calendar

Last Earnings
2/20/2018
Today
10/03/2022
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:TMED
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$522,750.00
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Glenn D. Yeik (Age 51)
    Interim Chairman, CEO & Pres
  • Mr. Brian T. Kenney (Age 62)
    VP of Global Sales & Marketing













TMED Stock - Frequently Asked Questions

How have TMED shares performed in 2022?

Trimedyne's stock was trading at $4.25 at the beginning of 2022. Since then, TMED stock has increased by 0.0% and is now trading at $4.25.
View the best growth stocks for 2022 here
.

How were Trimedyne's earnings last quarter?

Trimedyne, Inc. (OTCMKTS:TMED) posted its quarterly earnings results on Tuesday, February, 20th. The technology company reported $0.70 earnings per share (EPS) for the quarter. The technology company earned $1.53 million during the quarter.

What other stocks do shareholders of Trimedyne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include Aflac (AFL), Diana Shipping (DSX), Cohen & Steers Closed-End Opportunity Fund (FOF), Incyte (INCY), National Fuel Gas (NFG), PDC Energy (PDCE), The Rank Group (RNK), Safehold (SAFE), Snap (SNAP) and Aramark (ARMK).

What is Trimedyne's stock symbol?

Trimedyne trades on the OTCMKTS under the ticker symbol "TMED."

How do I buy shares of Trimedyne?

Shares of TMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trimedyne's stock price today?

One share of TMED stock can currently be purchased for approximately $4.25.

How much money does Trimedyne make?

Trimedyne (OTCMKTS:TMED) has a market capitalization of $522,750.00.

How can I contact Trimedyne?

Trimedyne's mailing address is 5 HOLLAND BLDG #223, IRVINE CA, 92618. The official website for the company is www.trimedyne.com. The technology company can be reached via phone at 949-951-3800 or via fax at 949-855-8206.

This page (OTCMKTS:TMED) was last updated on 10/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.